Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers
Clinical trial NCT06508645 · COMPLETED
Trial details
- NCT number
- NCT06508645
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2022-03-29
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.